Onconetix, Inc. (ONCO)
NASDAQ: ONCO · Real-Time Price · USD
0.5270
+0.0390 (7.99%)
At close: Mar 9, 2026, 4:00 PM EDT
0.5130
-0.0140 (-2.65%)
After-hours: Mar 9, 2026, 5:07 PM EDT
Onconetix Market Cap
Onconetix has a market cap or net worth of $819.49 thousand as of March 9, 2026. Its market cap has decreased by -86.59% in one year.
Market Cap
819.49K
Enterprise Value
88.71K
1-Year Change
-86.59%
Ranking
Category
Stock Price
$0.53
Market Cap Chart
Since the IPO on February 18, 2022, Onconetix's market cap has decreased from $634.08M to $819.49K, a decrease of -99.87%. That is a compound annual growth rate of -80.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 6, 2026 | 758.85K | -68.72% |
| Dec 31, 2025 | 2.43M | -53.58% |
| Dec 31, 2024 | 5.23M | 43.56% |
| Dec 29, 2023 | 3.64M | -78.61% |
| Dec 30, 2022 | 17.02M | -97.32% |
| Feb 18, 2022 | 634.08M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jaguar Health | 2.32M |
| Lyra Therapeutics | 2.28M |
| Bone Biologics | 2.21M |
| Adial Pharmaceuticals | 1.98M |
| Clearmind Medicine | 1.92M |
| CDT Equity | 1.91M |
| Ensysce Biosciences | 1.90M |
| CNS Pharmaceuticals | 1.82M |